This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Alchem sees decision, hearing report in EU pharma cartel fine issued

( February 3, 2026, 08:34 GMT | Official Statement) -- MLex Summary: Alchem has seen the European Commission issue a summary version of its July decision to fine the company almost €500,000 for fixing the minimum sales price for pharmaceutical input N-Butylbromide Scopolamine/Hyoscine — known as SNBB — and swapping commercial information with competitors. The final report of the hearing officer was also published Tuesday. The following documents are attached: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login